CNSystems Medizintechnik AG, a medical technology firm out of Graz, Austria, has received FDA approval to market the company’s CNAP™ Monitor 500, that performs continuous noninvasive blood pressure monitoring. The unit can be used in conjunction with other monitoring systems or alone as a self contained, battery powered unit.
More about the technology and the device from the press release:
CNAP™ traces blood pressure changes through the patented CNAP™ cuff at the fingers and calibrates the derived values once in a while to an upper arm measurement. This way the physician is provided with blood pressure values is the one he/she is familiar with and the patient’s individual physiology is optimally taken care of. If the position of measurement is changed relatively to heart height, just trigger a new upper arm measurement for the recalibration to the new measurement situation…
The CNAP™ Monitor 500 measures non-invasive and continuous blood pressure in real-time and can predict responsiveness to fluid administration. In the perioperative setting, detecting blood pressure drops and their cause in time is crucial for peri- and postoperative outcome. However, until recently only invasive methods provided quality information to the clinician. CNAP™ provides reliable blood pressure monitoring comparable to invasive techniques and adds valuable information about fluid responsiveness of the patient non-invasively. This allows spreading the highest level of blood pressure monitoring to all perioperative settings where close blood pressure monitoring is indicated, but the risk and discomfort of invasive measurement is not justified.
Product page: CNAP™ Monitor 500 …
Product brochure (.pdf)…
Press release: CNSystems Medizintechnik AG Receives FDA Approval for CNAP(TM) Monitor 500…